PortfoliosLab logoPortfoliosLab logo
NVS vs. AMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVS vs. AMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and American Tower Corporation (AMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVS achieves a 16.71% return, which is significantly higher than AMT's 0.68% return. Over the past 10 years, NVS has outperformed AMT with an annualized return of 10.49%, while AMT has yielded a comparatively lower 6.72% annualized return.


NVS

1D
-1.45%
1M
-2.35%
6M
8.22%
YTD
16.71%
1Y
39.55%
3Y*
18.79%
5Y*
15.30%
10Y*
10.49%
ALL TIME*
9.10%

AMT

1D
-0.63%
1M
4.41%
6M
-1.40%
YTD
0.68%
1Y
-15.11%
3Y*
0.23%
5Y*
-6.44%
10Y*
6.72%
ALL TIME*
9.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$617.52M$543.49M$581.60M
$287.25M$275.96M$277.92M

NVS vs. AMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NVS
Novartis AG
16.71%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%
AMT
American Tower Corporation
0.68%-0.92%-12.16%5.37%-25.67%32.89%-0.48%47.87%13.32%37.71%

Correlation

The correlation between NVS and AMT is 0.25, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.25

Correlation (3Y)
Balances recent behavior with more history.

0.30

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.30

Correlation (10Y)
Provides a long-term view across more market conditions.

0.29

Correlation (All Time)
Calculated using the full available price history since Jun 5, 1998

0.25

Fundamentals

Market Cap

NVS:

$296.80B

AMT:

$80.78B

EPS

NVS:

$6.63

AMT:

$7.22

PE Ratio

NVS:

23.56

AMT:

24.01

PEG Ratio

NVS:

1.59

AMT:

6.85

PS Ratio

NVS:

5.40

AMT:

7.41

PB Ratio

NVS:

7.19

AMT:

21.75

Total Revenue (TTM)

NVS:

$55.63B

AMT:

$10.94B

Gross Profit (TTM)

NVS:

$41.41B

AMT:

$8.01B

EBITDA (TTM)

NVS:

$22.26B

AMT:

$7.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVS vs. AMT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NVS
NVS Risk / Return Rank: 8989
Overall Rank
NVS Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 8989
Sortino Ratio Rank
NVS Omega Ratio Rank: 8787
Omega Ratio Rank
NVS Calmar Ratio Rank: 8989
Calmar Ratio Rank
NVS Martin Ratio Rank: 8686
Martin Ratio Rank

AMT
AMT Risk / Return Rank: 2020
Overall Rank
AMT Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
AMT Sortino Ratio Rank: 1919
Sortino Ratio Rank
AMT Omega Ratio Rank: 2020
Omega Ratio Rank
AMT Calmar Ratio Rank: 2020
Calmar Ratio Rank
AMT Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NVS vs. AMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and American Tower Corporation (AMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVSAMTDifference
Sharpe ratioReturn per unit of total volatility

+2.46

Sortino ratioReturn per unit of downside risk

+3.30

Omega ratioGain probability vs. loss probability

1.33

0.93

+0.40

Calmar ratioReturn relative to maximum drawdown

3.29

-0.65

+3.95

Martin ratioReturn relative to average drawdown

7.73

-1.02

+8.75

NVS vs. AMT - Sharpe Ratio Comparison

The current NVS Sharpe Ratio is 1.93, which is higher than the AMT Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of NVS and AMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVS vs. AMT - Drawdown Comparison

The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum AMT drawdown of -98.70%. Use the drawdown chart below to compare losses from any high point for NVS and AMT.


Loading charts...

Drawdown Indicators


NVSAMTDifference

Max Drawdown

Largest peak-to-trough decline

-42.10%

-98.70%

+56.60%

Max Drawdown (1Y)

Largest decline over 1 year

-12.65%

-20.94%

+8.29%

Max Drawdown (3Y)

Largest decline over 3 years

-19.95%

-28.40%

+8.45%

Max Drawdown (5Y)

Largest decline over 5 years

-20.42%

-45.34%

+24.92%

Max Drawdown (10Y)

Largest decline over 10 years

-26.03%

-45.34%

+19.31%

Current Drawdown

Current decline from peak

-4.58%

-33.24%

+28.66%

Average Drawdown

Average peak-to-trough decline

-10.90%

-27.05%

+16.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.38%

13.38%

-8.00%

Volatility

NVS vs. AMT - Volatility Comparison

Novartis AG (NVS) and American Tower Corporation (AMT) have volatilities of 7.89% and 8.09%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVSAMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.89%

8.09%

-0.20%

Volatility (6M)

Calculated over the trailing 6-month period

16.05%

21.36%

-5.31%

Volatility (1Y)

Calculated over the trailing 1-year period

21.74%

25.68%

-3.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.28%

26.84%

-7.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.73%

26.41%

-6.68%

Dividends

NVS vs. AMT - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.06%, less than AMT's 4.03% yield.


PositionTTM20252024202320222021202020192018201720162015
AMT
American Tower Corporation
4.03%3.87%3.53%2.99%2.77%1.78%2.02%1.64%1.99%1.84%2.05%1.87%
NVS
Novartis AG
3.06%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

NVS vs. AMT - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and American Tower Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

NVS vs. AMT - Profitability Comparison

The chart below illustrates the profitability comparison between Novartis AG and American Tower Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a gross profit of 10.74B and revenue of 14.42B. Therefore, the gross margin over that period was 74.5%.

AMT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, American Tower Corporation reported a gross profit of 2.01B and revenue of 2.75B. Therefore, the gross margin over that period was 73.0%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported an operating income of 4.74B and revenue of 14.42B, resulting in an operating margin of 32.8%.

AMT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, American Tower Corporation reported an operating income of 1.27B and revenue of 2.75B, resulting in an operating margin of 46.2%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a net income of 3.27B and revenue of 14.42B, resulting in a net margin of 22.7%.

AMT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, American Tower Corporation reported a net income of 867.50M and revenue of 2.75B, resulting in a net margin of 31.6%.


Frequently Asked Questions


NVS and AMT have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMT has higher volatility (8.09%) compared to NVS (7.89%). In terms of maximum drawdown, NVS dropped -42.10% vs AMT's -98.70%.

NVS currently has the higher Sharpe Ratio (1.93 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVS and AMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer